U.S. House of Representatives Debates Bill That Legalizes Medical Marijuana


U.S. House of Representatives Debates Bill That Legalizes Medical Marijuana A bill was introduced in the U.S. House of Representatives on Monday that seeks to have the Controlled Substances Act amended to legalize the use of marijuana with very low amounts of THC, the chemicals that gives users the characteristic high.

If the three-page bill is approved, it will be the first time that medical marijuana use is allowed under federal law, reported CNN.

“No one should face a choice of having their child suffer or moving to Colorado and splitting up their family,” said Rep. Scott Perry (R-Pennsylvania), who is sponsoring the bill. “We live in America, and if there’s something that would make my child better and they can’t get it because of the government, that’s not right.”

The bill may sail through if the Congress reads the mood on the ground; this year alone, 11 U.S. states have approved laws that allow the use of medical marijuana with low THC levels.


The bill is named the Charlotte’s Web Medical Hemp Act of 2014, named in honor of Charlotte Figi, a Colorado girl who has successfully controlled seizures using hemp oil.

Thanks in part to the efforts by Figi’s parents to promote the perceived benefits of the drug and partly to intense media coverage; several families have flocked to Colorado hoping to access the low-THC Charlotte’s Web marijuana strain, which is processed into hemp oil and administered to epileptic patients.

However, Perry’s Bill seeks to have any marijuana strain that contains less than 0.3 percent THC and higher levels of a compound known as cannabidiol, which is thought to control seizures. However, no research has been conducted to prove this claim.

Marijuana is considered a Schedule 1 drug under the 1970 Controlled Substances Act, which means it has “no currently accepted medical use and has a high potential for abuse”.To register for a free 2-week subscription to ForexMinute Premium Plan, visit www.forexminute.com/newsletter.

To contact the reporter of this story; Jonathan Millet at john@forexminute.com